Curriculum Vitae

PERSONAL DETAILS
ADMINISTRATIVE DUTIES
(Role),(Level),(Duration)
  • Deputy Dean (Value Creation and Enterprise), UNIVERSITI MALAYA, 01/08/2022 to present
  • Head of Department, UNIVERSITI MALAYA, 03/11/2020 to 31/07/2022
  • Committee Member, University Malaya, 04/11/2020 to 04/11/2021
  • HEAD COORDINATOR, Faculty, 01/04/2013 to 31/03/2015
ACADEMIC QUALIFICATION
(Qualification),(Field),(Institution),(Year)
  • FRCS (Urology), UROLOGY, ROYAL COLLEGE OF SURGEONS IN IRELAND, UK
  • FEBU, UROLOGY, European Board of Urology
  • MASTER OF SURGERY, UM (2002), SURGERY, UNIVERSITI MALAYA (UM)
  • FRCSI, SURGERY, ROYAL COLLEGE OF SURGEONS OF IRELAND
  • MBBS, UM (1995), PERUBATAN DAN PEMBEDAHAN, UNIVERSITI MALAYA (UM)
SPECIALIZATION
(Area)
Area of Expertise
  • UROLOGY
  • Research Interest
  • Illicit ketamine related cystitis and its reversibility. (Ketamine, abuse, cystitis)
  • A prospective, randomized, double-blind, placebo- controlled, parallel-group, multicenter study of the efficacy and safety of dapoxetine in men with premature ejaculation and concomitant erectile dysfunction treated with a phosphodiesterase-5 inhibitor (premature ejaculation, erectile dysfunction, dapoxetine)
  • Axitinib for the treatment of metastatic renal cell cancer (renal cell carcinoma, metastasis, axitinib)
  • TEACHING
    (Course Title),(Level of Study),(Institution),(Academic Session)
    Teaching
  • SURGERY - Phase 3a, First Degree, UNIVERSITY MALAYA (2010/2011 - 1 2 3 )
  • UROLOGY - Malaysian Advanced Urology Training Programme, Post Graduate, UNIVERSITY MALAYA (2010/2011 - 1 2 3 )
  • CLINICAL - Phase 2, First Degree, UNIVERSITY MALAYA (2010/2011 - )
  • UROLOGY - Master in Surgery, Post Graduate, UNIVERSITY MALAYA (2010/2011 - )
  • PUBLICATIONS
    (Title of publication in APA style)
    Refereed Journals
    2021
    • Chai CA, Yeoh WS, Rajandram R, Aung KP, Ong TA, Kuppusamy S, Nazran A, Kumaran K, Razack AHA, Teoh JY (2021). Comparing CxBladder to Urine Cytology as Adjunct to Cystoscopy in Surveillance of Non-muscle Invasive Bladder Cancer-A Pilot Study. Frontiers of Surgery 8: 659292. doi: 10.3389/fsurg.2021.659292. (WoS)
    • Dasgupta R, Ong TA, Lim J, Rajandram R, Gao X, Hakim L, Mburugu P, Ajmera R, Yuruk E, Pu Y-S, Geavlete P, Azhar RA, Mutambirwa S, Baard J (2021). A Global Perspective of Stenting after Ureteroscopy: an Observational Multicenter Cohort Study. Soci t Internationale d'Urologie Journal 2 (2), 96 105 (Non-WoS/Non-SCOPUS)
    • Lim J, Onozawa M, Saad M, Ong TA; A-CaP (Asian Prostate Cancer) Study; J-CaP (Japan Prostate Cancer Study Group); M-CaP (Malaysia Prostate Cancer Study Group), Malek R, Akaza H (2021). Recent trend of androgen deprivation therapy in newly diagnosed prostate cancer patients: Comparing between high- and middle-income Asian countries. Cancer Sci. 112: 2071-2080. doi: 10.1111/cas.14889. (WoS)
    • Amat, N., Philip, E.F., Chai, C.A., Yeoh, W.S., Lim, J., Fadzli, A.N., Kuppusamy, S. & Ong, T.A. (2021). The impact of population lockdown on the referral pattern for urology in a COVID-19 designated tertiary hospital in Malaysia. Urological Science, 32(1), 23-26.
    • Yow, H. Y., Tiong, J., Mai, C. W., van der Werf, E., Zainuddin, Z. M., Toh, C. C., Ngoo, K. S., Goh, E. H., Fadzli, A. N., Lok, S. H., & Ong, T. A. (2021). Prevalence of nocturia among community-dwelling adults: a population-based study in Malaysia. BMC urology, 21(1), 95. https://doi.org/10.1186/s12894-021-00860-1
    • Ngoo, K. S., Fadzli, A.N., Amponin, M.O.C.S.E., Cho, S.Y., Chuang, Y.C., Horiguchi, A., Karthikeyan, V.S., Morshed, M.S., Situmorang, G.R., Tan, T.C., Teoh, J.Y.C., Thaidumrong, T., & Ong, T. A. (2021). COVID 19 pandemic impact on urology residencies in Asia An observational study. Surgical Practice, 25(1), 10-15.
    • Yap, X. L., Wood, B., Ong, T. A., Lim, J., Goh, B. H., & Lee, W. L. (2021). Detection of Prostate Cancer via IR Spectroscopic Analysis of Urinary Extracellular Vesicles: A Pilot Study. Membranes, 11(8), 591. https://doi.org/10.3390/membranes11080591
    2020
    • Lim, J., Hinotsu, S., Onozawa, M., Malek, R., Sundram, M., Teh, G. C., Ong, T. A., Thevarajah, S., Zainal, R., Khoo, S. C., Omar, S., Nasuha, N. A., & Akaza, H. (2020). Modified J-CAPRA scoring system in predicting treatment outcomes of metastatic prostate cancer patients undergoing androgen deprivation therapy. Cancer medicine, 9(24), 9346 9352. https://doi.org/10.1002/cam4.3548 (WoS)
    • Ramasandran, G., Yen, K.S., Mat, S., Kamaruzzaman, S.B., Vyrn, C.A., Aik, O.T., Razack, A.H.A. & Pin, T.M. (2020). Ethnic differences in urinary incontinence among women aged 55 years and over: results from the Malaysian Elders Longitudinal Research (MELOR). Journal of Health and Translational Medicine, 23(1), 18-22. (WoS)
    • Teoh, J. Y., Cho, C. L., Wei, Y., Isotani, S., Tiong, H. Y., Ong, T. A., Kijvikai, K., Chu, P. S., Chan, E. S., Ng, C. F., & Asian Urological Surgery Training & Education Group (2020). Surgical training for anatomical endoscopic enucleation of the prostate. Andrologia, 52(8), e13708. https://doi.org/10.1111/and.13708 (WoS)
    • Perumal, K., Mun, K. S., Yap, N. Y., Razack, A., Gobe, G. C., Ong, T. A., Kuppusamy, S., & Rajandram, R. (2020). A Study on the Immunohistochemical Expressions of Leptin and Leptin Receptor in Clear Cell Renal Cell Carcinoma. BioMed research international, 2020, 3682086. https://doi.org/10.1155/2020/3682086 (WoS)
    • Yii, R., Lim, J., Sothilingam, S., Yeoh, W. S., Fadzli, A. N., Ong, T. A., Kuppusamy, S., & Abdul Razack, A. H. (2020). Predictive factors of prostate cancer diagnosis with PSA 4.0-10.0 ng/ml in a multi-ethnic Asian population, Malaysia. Asian journal of surgery, 43(1), 87 94. https://doi.org/10.1016/j.asjsur.2019.02.014 (WoS)
    • Lim, J., Amantakul, A., Shariff, N., Lojanapiwat, B., Alip, A., Ong, T. A., Thevarajah, S., Ahmayuddin, F., Mathew, A., Sriplakich, S., Vuthiwong, J., Chong, F., & Saad, M. (2020). Clinical outcomes of abiraterone acetate and predictors of its treatment duration in metastatic castration-resistant prostate cancer: Real-world experience in the Southeast Asian cohort. Cancer medicine, 9(13), 4613 4621. https://doi.org/10.1002/cam4.3101 (WoS)
    • Jalil, N. B., Lee, P. Y., Nor Afiah, M. Z., Abdullah, K. L., Azizi, F., Rassip, N., Ong, T. A., Ng, C. J., Lee, Y. K., Cheong, A. T., Razack, A. H., Saad, M., Alip, A., Malek, R., Sundram, M., Omar, S., Sathiyananthan, J. R., & Kumar, P. (2020). Effectiveness of Decision Aid in Men with Localized Prostate Cancer: a Multicenter Randomized Controlled Trial at Tertiary Referral Hospitals in an Asia Pacific Country. Journal of cancer education : the official journal of the American Association for Cancer Education, 10.1007/s13187-020-01801-6. (WoS)
    • Ng, C. J., Teo, C. H., Ang, K. M., Kok, Y. L., Ashraf, K., Leong, H. L., Taher, S. W., Mohd, S. Z., Zakaria, Z. F., Wong, P. F., Hor, C. P., Ong, T. A., Hussain, H., V, P., Ng, C. W., Agamutu, K., & Abd Razak, M. A. (2020). Barriers to implementing a national health screening program for men in Malaysia: An online survey of healthcare providers. Malaysian family physician : the official journal of the Academy of Family Physicians of Malaysia, 15(1), 6 14. (SCOPUS)
    • de la Rosette, J., Laguna, P., lvarez-Maestro, M., Eto, M., Mochtar, C. A., Albayrak, S., Mendoza-Valdes, A., Ong, T. A., Khadgi, S., Al-Terki, A., Bolton, D., Gomez, R., Klotz, L., Kulkarni, S., Tanguay, S., Gravas, S., & Soci t Internationale d Urologie Board of Directors (2020). Cross-continental comparison of safety and protection measures amongst urologists during COVID-19. International journal of urology : official journal of the Japanese Urological Association, 27(11), 981 989. https://doi.org/10.1111/iju.14340 (SCOPUS)
    2019
    • Yap, N. Y., Ong, T. A., Morais, C., Pailoor, J., Gobe, G. C., & Rajandram, R. (2019). Establishment of epithelial and fibroblast cell cultures and cell lines from primary renal cancer nephrectomies. Cell biology international, 43(6), 715 725. https://doi.org/10.1002/cbin.11150 (WoS)
    • Saad, M., Alip, A., Lim, J., Abdullah, M. M., Chong, F., Chua, C. B., Ismail, F., Khong, R. K., Lim, C. S., Loh, C. S., Malek, R., Mohd Ghani, K. A., Md Noor, I., Md Yusoff, N. A., Nasuha, N. A., Razack, A., Soo Hoo, H. F., Sundram, M., Tan, H. M., Thiagarajan, M., The, G. C., Voon, P. J., & Ong, T. A. (2019). Management of advanced prostate cancer in a middle-income country: real-world consideration of the Advanced Prostate Cancer Consensus Conference 2017. BJU international, 124(3), 373 382. https://doi.org/10.1111/bju.14807 (WoS)
    • Perumal, K., Huin, W. K., Yap, N. Y., Ong, T. A., Gobe, G. C., & Rajandram, R. (2019). Role of leptin as a biomarker for early detection of renal cell carcinoma? No evidence from a systematic review and meta-analysis. Medical hypotheses, 129, 109239. https://doi.org/10.1016/j.mehy.2019.109239 (WoS)
    • Youl Lee, J., Taniguchi, T., Zhang, K., Ng, C. F., Hakim, L., Umbas, R., Kim, C. S., Chung, B. H., Kim, W. J., Aik Ong, T., Lim, J., & Akaza, H. (2019). Report of the forth Asian Prostate Cancer (A-CaP) study meeting. Japanese journal of clinical oncology, 49(6), 581 586. https://doi.org/10.1093/jjco/hyz053 (WoS)
    • Aldoghachi, A. F., Baharudin, A., Ahmad, U., Chan, S. C., Ong, T. A., Yunus, R., Razack, A. H., Yusoff, K., & Veerakumarasivam, A. (2019). Evaluation of CERS2 Gene as a Potential Biomarker for Bladder Cancer. Disease markers, 2019, 3875147. https://doi.org/10.1155/2019/3875147 (WoS)
    • Lojanapiwat, B., Lee, J. Y., Gang, Z., Kim, C. S., Fai, N. C., Hakim, L., Umbas, R., Ong, T. A., Lim, J., Letran, J. L., Chiong, E., Lee, S. H., T rkeri, L., Murphy, D. G., Moretti, K., Cooperberg, M., Carlile, R., Hinotsu, S., Hirao, Y., Kitamura, T., Horie, S., Onozawa, M., Kitagawa, Y., Namiki, M., Fukagai, T., Miyazaki, J., & Akaza, H. (2019). Report of the third Asian Prostate Cancer study meeting. Prostate international, 7(2), 60 67. https://doi.org/10.1016/j.prnil.2018.06.001 (WoS)
    • Lim, H. C., Khong, T. L., Ong, T. A., Roslani, A. C., & Ang, C. W. (2019). Case report: A rare case of extravesical, extraperitoneal metastasis after transuretheral resection of urothelial carcinoma. Urology case reports, 29, 101017. https://doi.org/10.1016/j.eucr.2019.101017 (WoS)
    • Chiong, E., Murphy, D. G., Akaza, H., Buchan, N. C., Chung, B. H., Kanesvaran, R., Khochikar, M., Letran, J., Lojanapiwat, B., Ng, C. F., Ong, T., Pu, Y. S., Saad, M., Schubach, K., T rkeri, L., Umbas, R., Le Chuyen, V., Williams, S., Ye, D. W., ANZUP Cancer Trials Group, Davis, I. D. (2019). Management of patients with advanced prostate cancer in the Asia Pacific region: 'real-world' consideration of results from the Advanced Prostate Cancer Consensus Conference (APCCC) 2017. BJU international, 123(1), 22 34. https://doi.org/10.1111/bju.14489 (WoS)
    • Zhu, C. Z., Ting, H. N., Ng, K. H., & Ong, T. A. (2019). A review on the accuracy of bladder cancer detection methods. Journal of Cancer, 10(17), 4038 4044. https://doi.org/10.7150/jca.28989 (WoS)
    • Teoh, J. Y., Cho, C. L., Wei, Y., Isotani, S., Tiong, H. Y., Ong, T. A., Kijvikai, K., Chu, P. S., Chan, E. S., Ng, C. F., & Asian Urological Surgery Training & Education Group (2019). A newly developed porcine training model for transurethral piecemeal and en bloc resection of bladder tumour. World journal of urology, 37(9), 1879 1887. https://doi.org/10.1007/s00345-018-2602-2 (WoS)
    2018
    • Yee, A., Loh, H. S., Ong, T. A., Ng, C. G., & Sulaiman, A. H. (2018). Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial of Bupropion as Treatment for Methadone-Emergent Sexual Dysfunction in Men. American journal of men's health, 12(5), 1705 1718. https://doi.org/10.1177/1557988318784152 (WoS)
    • Abd Ghafar, N. K., Alip, A., Ong, T. A., Yap, N. Y., & Saad, M. (2018). Efficacy, safety, and prognostic indicators of first-line sunitinib in patients with metastatic renal cell carcinoma: A single center experience. Journal of cancer research and therapeutics, 14(6), 1303 1311. https://doi.org/10.4103/0973-1482.189247 (WoS)
    • Ng, K. L., Yap, N. Y., Rajandram, R., Small, D., Pailoor, J., Ong, T. A., Razack, A. H., Wood, S. T., Morais, C., & Gobe, G. C. (2018). Nuclear factor-kappa B subunits and their prognostic cancer-specific survival value in renal cell carcinoma patients. Pathology, 50(5), 511 518. https://doi.org/10.1016/j.pathol.2018.03.003 (WoS)
    • Dadaev, T., Saunders, E. J., Newcombe, P. J., Anokian, E., Leongamornlert, D. A., Brook, M. N., Cieza-Borrella, C., Mijuskovic, M., Wakerell, S., Olama, A., Schumacher, F. R., Berndt, S. I., Benlloch, S., Ahmed, M., Goh, C., Sheng, X., Zhang, Z., Muir, K., Govindasami, K., Lophatananon, A., Kote-Jarai, Z. (2018). Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants. Nature communications, 9(1), 2256. https://doi.org/10.1038/s41467-018-04109-8 (WoS)
    • Ho, L. Y., Chu, P. S., Consigliere, D. T., Zainuddin, Z. M., Bolong, D., Chan, C. K., Eng, M., Huynh, D. N., Kochakarn, W., Lapitan, M., Le, D. K., Le, Q. D., Lee, F., Lojanapiwat, B., Nguyen, B. N., Ong, T. A., Reyes, B. J., Santingamkun, A., Tsang, W. C., & Abrams, P. (2018). Symptom prevalence, bother, and treatment satisfaction in men with lower urinary tract symptoms in Southeast Asia: a multinational, cross-sectional survey. World journal of urology, 36(1), 79 86. https://doi.org/10.1007/s00345-017-2097-2 (WoS)
    • Lim, J., Rampal, S., Razack, A., Malek, R., Sundram, M., Nasuha, N. A., Ooi, C. C., Ong, T. A., & Sothilingam, S. (2018). A Novel Calculator for Estimating Prostate Volume in Daily Urology Services. Urology, 118, 145 151. https://doi.org/10.1016/j.urology.2018.02.055 (WoS)
    • Yap, N. Y., Khoo, W. T., Perumal, K., Ng, K. A., Rajandram, R., Alip, A., Saad, M., & Ong, T. A. (2018). Practical updates in medical therapy for advanced and metastatic renal cell carcinoma. Urological Science, 29(3), 120-128. (SCOPUS)
    2017
    • Rajandram, R., Yap, N. Y., Ong, T. A., Mun, K. S., Mohamad Wali, H. A., Hasan, M. S., Razack, A., & Ali Mohd, M. (2017). Oral ketamine induced pathological changes of the urinary tract in a rat model. The Malaysian journal of pathology, 39(1), 47 53. (WoS)
    • Kim, C. S., Lee, J. Y., Chung, B. H., Kim, W. J., Fai, N. C., Hakim, L., Umbas, R., Ong, T. A., Lim, J., Letran, J. L., Chiong, E., Wu, T. L., Lojanapiwat, B., T rkeri, L., Murphy, D. G., Gardiner, R. A., Moretti, K., Cooperberg, M., Carroll, P., Mun, S. K., Hinotsu, S., Hirao, Y., Ozono, S., Horie, S., Onozawa, M., Kitagawa, Y., Kitamura, T., Namiki, M., & Akaza, H. (2017). Report of the Second Asian Prostate Cancer (A-CaP) Study Meeting. Prostate international, 5(3), 95 103. https://doi.org/10.1016/j.prnil.2017.03.006 (WoS)
    • Lee, P. Y., Ng, C. J., Ong, T. A., Lee, Y. K., Khatijah Lim, A., Cheong, A. T., & Azad Hassan, A. R. (2017). Post-treatment impact and needs of prostate cancer survivors in Malaysia; a qualitative study. Malaysian family physician : the official journal of the Academy of Family Physicians of Malaysia, 12(3), 18 24.
    2016
    • Mun, P. S., Ting, H. N., Mirhassani, S. M., Ong, T. A., Wong, C. M., Chong, Y. B. (2016). Prediction of chronic kidney disease using urinary dielectric properties and support vector machine. Journal of Microwave Power and Electromagnetic Energy, 50(3), 201-213. https://doi.org/10.1080/08327823.2016.1230927 (WoS)
    • Cheong, A. T., Lee, P. Y., Ng, C. J., Lee, Y. K., Ong, T. A., Abdullah, K. L., & Razack, A. H. A. (2016). Doctors' Approaches to Decision Support in Counseling Patients with Localized Prostate Cancer: An Asian Perspective. Sains Malaysiana, 45(6), 941-947. (WoS)
    • Lee, P. Y., Cheong, A. T., Ng, C. J., Lee, Y. K., Abdullah, K. L., Razack, A. H. A., & Ong, T. A. (2016). Supporting patients in making treatment decisions for early prostate cancer: a qualitative study of healthcare professionals views on barriers and challenges in an Asian country. Journal of Men's Health, 12(1), 18-24. https://doi.org/10.31083/jomh.v12i1.21 (WoS)
    • Rajandram, R., Ong, T. A., Razack, A. H., MacIver, B., Zeidel, M., & Yu, W. (2016). Intact urothelial barrier function in a mouse model of ketamine-induced voiding dysfunction. American journal of physiology. Renal physiology, 310(9), F885 F894. https://doi.org/10.1152/ajprenal.00483.2015 (WoS/SCOPUS)
    • Akaza, H., Hirao, Y., Kim, C. S., Oya, M., Ozono, S., Ye, D., Cooperberg, M., Hinotsu, S., Lee, J. Y., Zhu, G., Namiki, M., Horie, S., Chung, B. H., Chen, C. H., Fai, N. C., Hakim, L., Chiong, E., Letran, J., Umbas, R., Suzuki, K., Nishimura, K., Ong, T. A., Lojanapiwat, B., Wu, T. L., Kim, W. J., Murphy, D., Ogawa, O., Carroll, P., Naito, S., & Tsukamoto, T. (2016). Asia prostate cancer study (A-CaP Study) launch symposium. Prostate international, 4(3), 88 96. https://doi.org/10.1016/j.prnil.2016.03.001
    2015
    • Lee, Y. K., Lee, P. Y., Cheong, A. T., Ng, C. J., Abdullah, K. L., Ong, T. A., & Razack, A. H. (2015). To Share or Not to Share: Malaysian Healthcare Professionals' Views on Localized Prostate Cancer Treatment Decision Making Roles. PloS one, 10(11), e0142812. https://doi.org/10.1371/journal.pone.0142812 (WoS)
    • Lim, J., Bhoo-Pathy, N., Sothilingam, S., Malek, R., Sundram, M., Tan, G. H., Bahadzor, B., Ong, T. A., Ng, K. L., & Abdul Razack, A. H. (2015). Cardiovascular Risk Factors and Ethnicity Are Independent Factors Associated with Lower Urinary Tract Symptoms. PloS one, 10(6), e0130820. https://doi.org/10.1371/journal.pone.0130820 (WoS)
    • Ong, T. A., Khong, S. Y., Ng, K. L., Ting, J. R., Kamal, N., Yeoh, W. S., Yap, N. Y., & Razack, A. H. (2015). Using the Vibrance Kegel Device With Pelvic Floor Muscle Exercise for Stress Urinary Incontinence: A Randomized Controlled Pilot Study. Urology, 86(3), 487 491. https://doi.org/10.1016/j.urology.2015.06.022 (WoS)
    • Mun, P. S., Ting, H. N., Ong, T. A., Wong, C. M., Ng, K. H., & Chong, Y. B. (2015). A Study of Dielectric Properties of Proteinuria between 0.2 GHz and 50 GHz. PloS one, 10(6), e0130011. https://doi.org/10.1371/journal.pone.0130011 (WoS)
    • Mun, P. S., Ting, H. N., Chong, Y. B., & Ong, T. A. (2015). Dielectric properties of glycosuria at 0.2-50 GHz using microwave spectroscopy. Journal of Electromagnetic Waves and Applications, 29(17), 2278-2292. https://doi.org/10.1080/09205071.2015.1072480 (WoS)
    2014
    • Rajandram, R., Yap, N. Y., Pailoor, J., Razack, A. H., Ng, K. L., Ong, T. A., Morais, C., & Gobe, G. C. (2014). Tumour necrosis factor receptor-associated factor-1 (TRAF-1) expression is increased in renal cell carcinoma patient serum but decreased in cancer tissue compared with normal: potential biomarker significance. Pathology, 46(6), 518 522. https://doi.org/10.1097/PAT.0000000000000145 (WoS)
    • Lim, J., Bhoo-Pathy, N., Sothilingam, S., Malek, R., Sundram, M., Hisham Bahadzor, B., Ong, T. A., Ng, K. L., Sivalingam, S., & Razack, A. H. (2014). Ethnicity is an independent determinant of age-specific PSA level: findings from a multiethnic Asian setting. PloS one, 9(8), e104917. https://doi.org/10.1371/journal.pone.0104917 (WoS)
    • Lim, N. K., Aik, O. T., Meng, L. L., Htun, T. H., & Razack, A. H. (2014). Superior vena caval syndrome secondary to metastatic renal cell carcinoma. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 24 Suppl 1, S68 S70. (WoS/SCOPUS)
    2013
    • Ong, T. A., Yaakup, N. A., Sivalingam, S., & Razack, A. H. (2013). Hook wire localization for testis sparing surgery. Urology, 81(4), 904 907. https://doi.org/10.1016/j.urology.2012.10.077 (WoS)
    • Yap, N. Y., Ng, K. L., Ong, T. A., Pailoor, J., Gobe, G. C., Ooi, C. C., Razack, A. H., Dublin, N., Morais, C., & Rajandram, R. (2013). Clinical prognostic factors and survival outcome in renal cell carcinoma patients--a malaysian single centre perspective. Asian Pacific journal of cancer prevention : APJCP, 14(12), 7497 7500. https://doi.org/10.7314/apjcp.2013.14.12.7497 (WoS)
    2012
    • Loh, K. W., Vriens, M. R., Gerritsen, A., Borel Rinkes, I. H., van Hillegersberg, R., Schippers, C., Steenhagen, E., Ong, T. A., Moy, F. M., & Molenaar, I. Q. (2012). Unintentional weight loss is the most important indicator of malnutrition among surgical cancer patients. The Netherlands journal of medicine, 70(8), 365 369. (WoS)
    • Ng, K. L., Htun, T. H., Dublin, N., Ong, T. A., & Razack, A. H. (2012). Assessment and clinical significance of haematuria in Malaysian patients - relevance to early cancer diagnosis. Asian Pacific journal of cancer prevention : APJCP, 13(6), 2515 2518. https://doi.org/10.7314/apjcp.2012.13.6.2515 (WoS/SCOPUS)
    2010
    • Lee, P., Ong, T., Muna, S., Syed Alwi, S., & Kamarudin, K. (2010). Brief report do university students have high cardiovascular risk? A pilot study from Universiti Malaysia Sarawak (UNIMAS). Malaysian family physician : the official journal of the Academy of Family Physicians of Malaysia, 5(1), 41 43. (SCOPUS)
    • Lee, P., Ong, T., & Dayangku Norlida, A. (2010). Tuberculous prostatic abscess in an immunocompromised patient. Malaysian family physician : the official journal of the Academy of Family Physicians of Malaysia, 5(3), 145 147. (SCOPUS)
    2008
    • Ong, T. A., Winkler, M. H., Savage, P. M., Seckl, M. J., & Christmas, T. J. (2008). Retroperitoneal lymph node dissection after chemotherapy in patients with elevated tumour markers: indications, histopathology and outcome. BJU international, 102(2), 198 202. https://doi.org/10.1111/j.1464-410X.2008.07533.x (WoS)
    2007
    • Wong, J. S., Ong, T. A., Chua, H. H., & Tan, C. (2007). Acute anuric renal failure following jering bean ingestion. Asian journal of surgery, 30(1), 80 81. https://doi.org/10.1016/S1015-9584(09)60134-2 (WoS)
    2006
    • McNicholas, T., & Ong, T. (2006). Review of Testim gel. Expert opinion on pharmacotherapy, 7(4), 477 484. https://doi.org/10.1517/14656566.7.4.477 (WoS)
    2003
    • Ong, T. A., Peh, S. C., Goh, K. S., Naicker, M. S., Khan, A. F., Chua, B. C., & Razack, A. (2003). P53 protein expression in transitional cell carcinoma of the bladder - experience of the University of Malaya Medical Centre. Asian journal of surgery, 26(1), 31 36. https://doi.org/10.1016/S1015-9584(09)60212-8 (WoS)
    • Ong, T. A., & Yip, C. H. (2003). Short-term survival in breast cancer: the experience of the University of Malaya Medical Centre. Asian journal of surgery, 26(3), 169 175. https://doi.org/10.1016/S1015-9584(09)60378-X (WoS)
    Book Chapter
    2014
    • Rajandram, R., Ong, T. A., & Saad, M. (2014). Resistance of renal cell carcinoma to targeted therapy. Advances in Drug Resistance Research. New York: Nova Science Publishers, 203-24.
    RESEARCH PROJECT
    (Project title),(Role),(Duration),(Level)
    International Funding
  • A phase III, multicentre, randomised, double blind, parallel group, placebo controlled study to assess the efficacy and safety of one or more intradetrusor treatment of 600 or 800 units of Dysport for the treatment of urinary incontinence in subjects with neurogenic detrusor overactivity due to spina cord injury or multiple sclerosis, Consultant, 2016 - 2017 (International)
  • Analysis of The Cell Growth and Protein Secretion Capacity of Foreskin, Bladder and Ureter Cells With The Final Aim To Improve Medical Device Biocompatibility, Co-Researcher, 01/11/2020 to 01/11/2022, REGENOSCA SA (International)
  • Industry
  • KEYNOTE-052 : A Phase 2 Clinical Trial of Pembrolizumab in Subjects with advanced/ unresectable or metastatic urothelial cancer. , Consultant, 2015 - 2020 (International)
  • Medivation and Astella
  • PROSPER A multinational, Phase 3, Randomized, Double blinde, Placebo controlled, Efficacy and Safety of Enzalutamide in Patient With Nonmetastatic Castration-Resistant Prostate Canncer , Consultant, 2013 - 2018 (International)
  • Janssen Cilag
  • LATITUDE : A randomised double-blind comparative study of Zytiga (abiraterone acetate) plus low dose prednisolone plus androgen deprivation therapy (ADT) versus ADT alone in newly diagnosed subjects with high risk metastatic hormone-naive prostate cancer (mHNPC). LATITUDE, Consultant, 2012 - 2018 (International)
  • An Open Label Study of Abiraterone Acetate in Subjects with Metastatic Castration-Resistant Prostate Cancer Who Have Progressed After Taxane-Based Chemotherapy , Consultant, 2011 - 2013
  • Janssen Cilag (Johnson & Johnson)
  • ABI-PRO 3002 : A phase 3, randomized, double-blind, placebo-controlled study of abiraterone acetate (JNJ-212082) plus prednisone in asymptomic or mildly symptomatic patients with metastatic castration-resistant prostate cancer. , Consultant, 2012 - 2015 (National)
  • High Impact Research (HIR)
  • Large-scale profiling of Cancer/Testis Antigens (CTA) and the delineation of MiRNA-mediated reversal of CTA-associated aberrant demethylation in urothelial cell carcinoma, Principal Investigator(PI), 2012 - 2014
  • Geran Penyelidikan Universiti Malaya (UMRG)
  • Urinary tract and liver injury from long term oral ketamine, Principal Investigator(PI), 2012 - 2013 (National)
  • Caspase-8 and TRAF1 as biomarkers of progression of Renal Cell Carcinomas , Consultant, 2011 - 2012 (National)
  • UPM Research University Grant Scheme, RUGS
  • Developing and pilot-testing an intervention decision aid for patients with prostate cancer who are making decision about prostate cancer treatment, Consultant, 2012 - 2014 (National)
  • Sanofi-Aventis
  • Multicentre, single-arm, open label, clinical trial intended to provide early access to cabazitaxel in patients with metastatic hormone refractory prostate cancer previously treated with a docetaxel-containing regimen and to document safety of cabazitaxel in these patients. , Consultant, 2011 - 2012 (International)
  • Pfizer
  • AG-013736 (Axitinib) for the treatment of metastatic renal cell cancer., Consultant, 2010 - 2011 (International)
  • Johnson & Johnson
  • A prospective, randomized, double-blind, placebo- controlled, parallel-group, multicenter study of the efficacy and safety of dapoxetine in men with premature ejaculation and concomitant erectile dysfunction treated with a phosphodiesterase-5 inhibitor: COUPLE: COncomitant Use of PriLigy in Men Treated for Erectile Dysfunction , Consultant, 2010 - 2011 (International)
  • Fundamental Research Grant Scheme (FRGS)
  • Construing The Roles Of Adipokines And Their Mechanism In Renal Cell Carcinoma (rcc), Co-Researcher, 01/11/2020 to 30/04/2024, Kementerian Pendidikan Tinggi (KPT) (Government)
  • Deciphering Survival Strategies Of Uropathogenic Escherichia Coli (upec)in Establishing Urinary Tract Infections, Co-Researcher, 01/01/2019 to 30/09/2022, Kementerian Pendidikan Malaysia (KPM) (Government)
  • Establishing the role of histone H3 lysine 27(H3K27) demethylases in renal cell carcinoma and bladder cancers invasiveness and progression, Co-Researcher, 15/08/2017 to 14/09/2019, Kementerian Pendidikan Tinggi (KPT) (Government)
  • Establishing The Roles Of The Receptors Involved In The Purinergic Signalling Pathway In The Human Bladder, Principal Investigator(PI), 01/08/2016 to 28/02/2019, (e-finance) Kementerian Pengajian Tinggi (KPT) (Government)
  • Deciphering The Molecular Mechanisms And Therapeutic Potential Of Traf1 And Nf-kb In Renal Cell Carcinoma, Principal Investigator(PI), 01/12/2013 to 30/04/2016, Kementerian Pendidikan Tinggi (KPT) (Government)
  • RU Geran - Fakulti Program
  • Clinical And Molecular Investigation On The Role Of Cholesterol In Improving Drug Response In Bladder Cancer, Co-Researcher, 15/09/2020 to 14/09/2022, Research University (Government)
  • Others MOHE - Top 100 (IIRG)-HWB
  • Characterization Of Farnesyl Diphosphate Farnesyltransferase 1 (fdft1) Expression In Cisplatin -treated Muscle -invasive Bladder Cancer, Co-Researcher, 13/05/2019 to 12/05/2022, Kementerian Pendidikan Tinggi (KPT) (Government)
  • Geran Penyelidikan Universiti Malaya (UMRG) - AFR (Frontier Science)
  • Molecular profiling and pathway analysis of clinically aggressive Renal Cell Carcinoma , Co-Researcher, 15/11/2017 to 22/04/2020, Research University (Government)
  • Evaluation Of Urokinase Plasminogen Activator Receptor, Cytokines And Chemokines In Kidney Stone Diseases Pre And Post-percutaneous Nephrolithotomy (pcnl), Co-Researcher, 18/06/2014 to 13/06/2016, Research University (Government)
  • Postgraduate Research Grant (PPP) - Course & Disertation
  • Linguistic Translation and Validation of Nocturia Quality of Life (N-QOL) questionnaire, Principal Investigator(PI), 20/01/2016 to 20/01/2017, Research University (Government)
  • Grand Challenge - HTM (Wellness)
  • Lower Urinary Tract Symptoms And Sexual Dysfunction Among Patients With Osteoarthritis, Principal Investigator(PI), 05/09/2014 to 02/11/2019, (e-Finance) Research University (Government)
  • RU Geran
  • The Mechanism Of Ketamine Cystitis In A Rat Model, Principal Investigator(PI), 23/06/2014 to 30/06/2015, MOSTI- ANGKASA (Government)
  • Geran Penyelidikan Universiti Malaya (UMRG) - HTM (Wellness)
  • Traf1 And Nf-kb : Understanding And Evaluating The Molecular Mechanisms And Therapeutic Potential In Renal Cell Carcinoma, Co-Researcher, 08/10/2013 to 17/05/2016, Research University (Government)
  • Urinary Tract And Liver Injury From Long Term Oral Ketamine And Its Reversibility In A Rat Model., Principal Investigator(PI), 19/06/2012 to 30/06/2015, (e-Finance) Research University (Government)
  • Geran Penyelidikan Universiti Malaya (UMRG)
  • ILLICIT KETAMIN RELATED CYSTITIS AND ITS REVERSIBILITY, Principal Investigator(PI), 01/09/2010 to 31/08/2011
  • SUPERVISION
    External Supervision
    (Title of Thesis),(Name of Candidates),(Institution),(Academic Level)
    Completed
    • Establishment and characterisation of Malaysian urothelial cell carcinoma cell lines, LAI JIUN YEE, M0100103 (Post Graduate Student)
    • Molecular Genetics Analysis of Bladder Carcinoma: Gene Expression Profiling and Analysis of the p53 Gene Family, William Ngu Toh Leong, M0100108 (Post Graduate Student)
    • MicroRNA regulation of KDM5B in urothelial cell carcinoma, Radha a/p Kodiappan, M0100103 (Post Graduate Student)
    Postgraduate Student
    (Title of Thesis),(Name of Candidates),(Institution),(Academic Level)
    Completed
    • Colonic stenting versus emergency surgery for left sided malignant colonic obstruction: a single centre retrospective study, Devindran Manoharan, University of Malaya (UM) (Post Graduate Student)
    • DEMOGRAPHICS AND HISTOPATHOLOGY OF PATIENTS UNDERGOING TRANSRECTAL ULTRASOUND (TRUS) GUIDED PROSTATE BIOPSY IN QUEEN ELIZABETH HOSPITAL, KOTA KINABALU, SABAH., Dr Foo Siang Lin, University of Malaya (UM) (Post Graduate Student)
    • MEASUREMENT AND CLASSIFICATION OF URINARY DIELECTRIC PROPERTIES FOR TYPE 2 DIABETES MELLITUS AND CHRONIC KIDNEY DISEASE, MUN PECK SHEN, University of Malaya (UM) (Post Graduate Student)
    • A randomized controlled trial to compare the effectiveness of pelvic floor exercise with vibrance kegel device (VKD) with pelvic floor exercise alone for stress urinary incontinence in women: a pilot study, JESSE TING, University of Malaya (UM) (Post Graduate Student)
    Ongoing
    • Biomarker and prognostic indicators in renal cell carcinoma, Yap Ning Yi, University of Malaya (UM) (Post Graduate Student)
    • Validation of nocturia quality of life questionnaire, SONG Chun Hoong, University of Malaya (UM) (Post Graduate Student)
    • Deciphering of leptin and leptin receptor mechanism in renal cell carcinoma's resistance to targeted therapy, Komathi Perumal, University of Malaya (UM) (Post Graduate Student)
    SOCIAL RESPONSIBILITY ACTIVITIES
    (Contribution to Society),(Duration),(Level)
    • Public Health talk on Nocturia- PWTC, 21/11/2010 to 21/11/2010
    • Public health talk on erectile dysfunction (Damansara Residence Association), 22/08/2010 to 22/08/2010
    • Overactive bladder & benign prostate enlargement campaign, 19/06/2010 to 20/06/2010
    AWARD AND STEWARDSHIP
    (Name of Award/Stewardship),(Awarding Institution),(Year Awarded),(Type of Award)
    • CERTIFICATE OF EXCELLENT SERVICE, University of Malaya, 2018 (CERTIFICATE)
    • CERTIFICATE OF EXCELLENT SERVICE, University of Malaya, 2016 (CERTIFICATE)
    • CERTIFICATE OF EXCELLENT SERVICE, University of Malaya, 2015 (CERTIFICATE)
    • Poster Merit Award for Paper: Doctors' Approaches to Decision Support in Counselling Patients with Prostate Cancer, WONCA Asia Pacific Regional Conference 2014, 2014 (RESEARCH)
    • CERTIFICATE OF EXCELLENT SERVICE, University of Malaya, 2013 (CERTIFICATE)
    • Asian Preceptorship Programme, Singapore General Hospital, 2010 (SPECIAL)
    CONSULTANCY PROJECT
    (Project title),(Organisation),(Duration),(Role),(Level)
    • Committee for Subspecialty Training for Urology, Ministry of Health, Malaysia, Kementerian Kesihatan Malaysia, 01/11/2020 to 01/11/2022 (National)
    PAPER PRESENTED
    (Title),(Event),(Date Presented),(Organiser),(Level)
    PLENARY SPEAKER
  • Urothelial Carcinoma: Latest therapeutic advancement, Taiwan Urological Oncology Association Annual Scientific meeting, 07/01/2017 to 07/01/2017, Taiwan Urological Oncology Association, TUOA (International)
  • Current update on Overactive Bladder in 2016, 25th Malaysian Urological Conference, 25/11/2016 to 27/11/2016, Malaysian Urological Association (National)
  • Treatment of BPH 80 gram TUR-P, Prostate enucleation, Laser prostatectomy, open prostatectomy, 27th World Congress on Videourology & Advances in Clinical Urology, 09/06/2016 to 11/06/2016, Endourological Society (International)
  • What's the latest evidence with use of enzalutamide and abiraterone, and in what directions are they heading, Asian Prostate Cancer Forum (APCF) 2016, 02/04/2016 to 02/04/2016, Ferring (International)
  • ADT and cardiovascular risk: Asian experiences, Asian Prostate Cancer Forum (APCF) 2016, 02/04/2016 to 02/04/2016, Ferring (International)
  • Update on Female Tapes: When, Which and How, 23rd Malaysian Urological Conference 2014, 21/11/2014 to 23/11/2014, Malaysian Urological Association (National)
  • INVITED SEMINAR
  • Common Prostate Disorders, Public Talk on Prostate Disorders, 10/12/2016 to 10/12/2016, Sinchew Daily (National)
  • Urinary stone disease, Sinchew online video portal, 10/11/2016 to 10/11/2016, Sinchew Daily Headquarter (National)
  • INVITED SPEAKER
  • ADT in Advanced Prostate Cancer What s New for Malaysia Patients, Round table discussion on prostate cancer, 24/01/2017 to 24/01/2017, Ferring (National)
  • Principles of radical and partial nephrectomy, AUSTEG Laparoscopic Upper Tract Surgery Course, 14/01/2017 to 15/01/2017, Asian Urological Surgery Training and Education Group (AUSTEG) (International)
  • Case Studies Troubleshooting and management, AUSTEG Laparoscopic Upper Tract Surgery Course, 14/01/2017 to 15/01/2017, Asian Urological Surgery Training and Education Group (AUSTEG) (International)
  • Managing common prostate problems in primary care, Teaching session for Master of Family Medicine, 10/01/2017 to 10/01/2017, Department of Family Medicine, Faculty of Medicine, University of Malaya (University)
  • Surgical Management of Prostate Cancer, Prostate Pathology Assessment Seminar-Workshop, 17/11/2016 to 17/11/2016, Department of Pathology, Faculty of Medicine, University of Malaya (National)
  • What is BPH? Men's walnut problem, Health in the City 2016 (HITC 2016) public forum, 13/11/2016 to 13/11/2016, MIMS Medica (National)
  • Introduction to laparoscopic urologic operations, AUSTEG Urology Nursing Workshop, 05/11/2016 to 05/11/2016, Asian Urological Surgery Training and Education Group (International)
  • Laparoscopic pyeloplasty- the current trend and status, 3rd "Golden Bridge" International Urology Conference, 28/10/2016 to 30/10/2016, Kunming Medical University (International)
  • ED & BPH Two problems. One Solution, Malaysian Pharmacy Society CME, 23/10/2016 to 23/10/2016, Eli Lilly (National)
  • Practical Approach to BPH, Malaysian Pharmacy Society CME, 23/10/2016 to 23/10/2016, Eli Lilly (National)
  • Urology Masterclass, Urology Masterclass, 22/10/2016 to 22/10/2016, Eli Lilly (National)
  • Case Study Sharing- Prostate Cancer, Xtandi Expert Meeting, 23/09/2016 to 23/09/2016, Astellas (National)
  • The role of PSA testing, Melody FM Health Section, 19/09/2016 to 19/09/2016, Melody FM (National)
  • EAU guidelines updates, Art of Oncology 2016, 17/09/2016 to 17/09/2016, Sanofi (National)
  • Present status of the registration for the A-CaP in each country: Malaysia, 2nd A-Cap (Asia Pacific Prostate Cancer Registry) Meeting, 08/09/2016 to 08/09/2016, A-Cap Prostate Cancer Registry (International)
  • Key Publications in Uro-oncology 1 (kidney/bladder), MBU/FRCS(Urol) viva preparatory course, 03/09/2016 to 04/09/2016, UKM (National)
  • Sexual Dysfunction And Continence, Elderly living with OSTEOARTHRITIS: Promoting Independent and Quality Of Life, 29/08/2016 to 29/08/2016, The Grand Challenge PISA group and the Ageing and Age Associated Disorder Research Group, University of Malaya (National)
  • Men's Sexual Health, Adult Sexual Health Workshop, 27/08/2016 to 27/08/2016, AiFM (National)
  • Debate: LHRH against vs antagonists in Prostate Cancer, 3i Pathways Workshop, 13/08/2016 to 13/08/2016, Majestic Hotel, Kuala Lumpur (National)
  • Common Prostate Disorders, Public Talk on Prostate Disorders, 30/07/2016 to 30/07/2016, Sinchew Daily (National)
  • Sequential agents for CRPC - high costs, low yield?, 14th UAA Congress 2016, 20/07/2016 to 24/07/2016, Urological Association of Asia, UAA (International)
  • Benign Prostatic Hyperplasia, Cialis BPH Training and DKSH Field Force, 12/07/2016 to 12/07/2016, Eli Lilly (National)
  • Management of advanced prostate cancer, Prostate Cancer Training, 28/06/2016 to 28/06/2016, Ferring (National)
  • Effectiveness of Cialis once a day, Urology Masterclass, 20/05/2016 to 20/05/2016, Eli Lilly (University)
  • Case Sharing and Discussion 2: A Challenging Case of mCRPC, Focus Group Discussion: Treatment Sequencing in mCRPC, 29/04/2016 to 29/04/2016, Johnson & Johnson (National)
  • Hypogonadism and Men's Health, Sarawak Urology Update, 23/04/2016 to 23/04/2016, Malaysian Urological Association (National)
  • Practical approach for patient with Nocturia, Sarawak Urology Update, 23/04/2016 to 23/04/2016, Malaysian Urological Association (National)
  • Erectile Dysfunction: More Than Meets The Eye, Vitacare Staff Training, 13/04/2016 to 13/04/2016, Vitacare (National)
  • Laparoscopic nephrectomy, 5TH Urology Laparoscopic Workshop, 11/04/2016 to 12/04/2016, UKM (National)
  • Effectiveness of Cialis Once a Day, Urology Masterclass, 30/03/2016 to 30/03/2016, Eli Lilly (National)
  • Urinary tract infection, Men s Health Academy, 26/03/2016 to 26/03/2016, Pfizer (National)
  • Incontinence in Male Older Adult and Benign Prostate Hyperplasia, Geriatric Training Day, Incontinence in Elderly, 23/03/2016 to 23/03/2016, Unit of Geriatrics, Department of Medicine, Faculty of Medicine, University of Malaya (University)
  • Nocturia, Malaysian Enterostomal Therapy Nursing Education Program (Malaysian ETNEP), 09/03/2016 to 09/03/2016, Enterostomal Therapy Team, University Malaya Medical Centre, Kuala Lumpur (International)
  • Kidney stone- an overview, NTV7 Health Talk Show, 08/03/2016 to 08/03/2016, NTV7 (National)
  • Urostoma, Malaysian Enterostomal Therapy Nursing Education Program (Malaysian ETNEP), 02/03/2016 to 02/03/2016, Enterostomal Therapy Team, University Malaya Medical Centre, Kuala Lumpur (International)
  • Prostate Cancer Update and Disease Training, Sanofi Staff Training Session, 21/01/2016 to 21/01/2016, Sanofi (National)
  • Prostate Cancer Case Sharing, ESOU- Ipsen South Asia Symposium, 17/01/2016 to 17/01/2016, Ipsen (International)
  • Daily dosing for ED- what s the rationale?, Primary Care Workshop, 04/10/2015 to 04/10/2015, MALAYSIAN MEDICAL ASSOCIATION, MELAKA BRANCH (National)
  • One man two problems , one solution, Primay Care Workshop, 04/10/2015 to 04/10/2015, MALAYSIAN MEDICAL ASSOCIATION, MELAKA BRANCH (National)
  • Managing ED for Prostate Cancer Survivors, Prostate Cancer Talk, 27/09/2015 to 27/09/2015, Prostate Cancer Support Group (National)
  • Importance of Multidisciplinary team approach in the management of prostate cancer, Art of Oncology, 06/12/2014 to 06/12/2014, Sanofi-Aventis Malaysia (National)
  • Nocturia: Time to Wake Up, Urology Frontier, 30/11/2014 to 30/11/2014, Ferring (International)
  • Update on Female Tapes: When, Which and How, 23rd Malaysian Urological Conference, 23/11/2014 to 23/11/2014, Malaysia Urological Association, MUA (National)
  • Research in Urology (selected highlights): Ketamine bladder: What have we learned from animal studies?, 34th Congress of the Societe Internationale D'Urologie, 12/10/2014 to 15/10/2014, Societe Internationale D'Urologie (International)
  • Imaging of Cancers in Urology, Annual Scientific Meeting of the College of Surgeons, Academy of Medicine Malaysia, 23/05/2014 to 25/05/2014, College of Surgeons, Academy of Medicine Malaysia (National)
  • Management of Early Prostate Cancer, WONCA Asia Pacific Regional Conference 2014, 22/05/2014 to 24/05/2014, The Academy of Family Physicians of Malaysia (International)
  • Micturition: Anatomy and Physiology, Contemporary Management of Incontinence (CMI) Course 2013 , 25/09/2013 to 25/09/2013, Continence Unit, UMMC (National)
  • Extending the duration,Expanding the horizon the Tadalafil way, MIMSCPD Workshop on Urology, 22/09/2013 to 22/09/2013, MIMSCPD (National)
  • ED, CVD and Diabetes: What s the Link? , Pharmacy in Health Transformation Seminar, 20/09/2013 to 20/09/2013, Malaysian Pharmaceutical Society (National)
  • What is the role of PDE5-inhibitors on penile rehabilitation post-prostatectomy (TURP/TVP), Asia Urology Scientific Forum, 29/06/2013 to 29/06/2013, Lilly (International)
  • Urology Surgery, 20TH NATIONAL PERIOPERATIVE NURSING SEMINAR 2013 , 25/06/2013 to 25/06/2013, MNA Perioperative Special Interest Group (National)
  • ED, cardiovascular risk and diabetes : Why early diagnosis is important?, PHAME Multidisciplinary Workshop for Pharmacists, 19/05/2013 to 19/05/2013, Pfizer (National)
  • Management Pathway for PCa Patients with Bone Mets (In Malaysia), GSK Asia Pacific Advisory Board: Prostate Cancer Patients with Bone Metastases, 18/05/2013 to 18/05/2013, GSK Service Unlimited (International)
  • Challenges in the treatment of urinary tract infection, 1st MMA-MIMS CPD National Scientific Conference, 15/03/2013 to 15/03/2013, MIMS CPD (National)
  • Integration of the role of urologists and oncologists in the treatment of urological cancers. , MOS-MUA collaboration scientific meeting (RCC), 18/12/2010 to 18/12/2010, GSK (National)
  • Guideline and practice of lower urinary tract symptoms treatment in Malaysia, ASEAN LUTS expert meeting, 27/11/2010 to 27/11/2010, Astella, Japan. (International)
  • Vesicovaginal and ureterovaginal fistulae and Nocturia , Continence Seminar , 13/10/2010 to 15/10/2010, Malaysian Continence Foundation (National)
  • Erectile dysfunction , Erectile dysfunction , 22/08/2010 to 22/08/2010, Bayer (Others)
  • Management of Iatrogenic Ureteric Injuries & How to Avoid Them, College of Surgeons AGM and Annual Scientific Meeting, 29/05/2010 to 29/05/2010, College of Surgeons (National)
  • PRIMED GP Workshop on Premature Ejaculation (on dapoxetine), GP Workshop , 02/05/2010 to 02/05/2010, Faculty of Medicine, University Malaysia Sarawak, Kuching (National)
  • Evaluation of patients presented with LUTS and OAB- practical management plan, Evaluation of patients presented with LUTS and OAB- practical management plan, 27/04/2010 to 27/04/2010, GSK (National)
  • Evaluation of patients presented with LUTS and OAB- practical management plan, Office Urology- Focus on BPH and OAB- Family Physician Perspective, 28/03/2010 to 28/03/2010, GSK (National)
  • EVENT ORGANISER
  • 23rd Malaysian Urological Conference 2014, 23rd Malaysian Urological Conference 2014, 21/11/2014 to 23/11/2014, Malaysian Urological Association (National)
  • ORAL PRESENTER
  • Urokinase and its receptor expression in patients undergone percutaneous nephrolithotomy TA Ong,R Rajandram,Lucy Chan,Azad Hassan Razack,Puspha Jayasihman,Hemalatha.S, 25th Malaysian Urological Association Conference Humanising Technology in Urology,, 25/11/2016 to 27/11/2016, Malaysian Urological Association (International)
  • POSTER PRESENTER
  • TA Ong, R Rajandram,Lucy Chan,Azad Hassan Razack,Puspha Jayasihman,Hemalatha.The expression of inflammatory cytokines cases of percutaneous nephrolithotomy., 25th Malaysian Urological Association Conference Humanising Technology in Urology, 25/11/2016 to 27/11/2016, Malaysian Urological Association (International)
  • PATHOLOGICAL CHANGES OF THE URINARY TRACT FROM ORAL KETAMINE AND ITS REVERSIBILITY IN A RAT MODEL., USANZ (Urological Society of Australia and New Zealand), 17/03/2014 to 19/03/2014, Urological Society of Australia and New Zealand (International)
  • PRESENTER
  • Impact and Needs of Prostate Cancer Survivors in a Country with Low Incidence of Prostate Cancer, PCWC 2015 (Prostate Cancer World Congress), 17/08/2015 to 21/08/2015, PCWC 2015 Congress Organisers (International)
  • Viva on BPH management in the elderly, Advanced Urology Workshop on BPH, 22/05/2014 to 22/05/2014, College of Surgeons, Academy of Medicine, and Malaysian Urological Association (National)
  • OTHERS
  • Semi-live surgery 2, Urology Symposium 2016, 04/11/2016 to 05/11/2016, Division of Urology, Department of Surgery, Chinese University of Hong Kong (International)
  • Session XII: Prostate Cancer, Asia Pacific Prostate Society (APPS) Conference, 09/09/2016 to 10/09/2016, APPS (International)
  • Present status of the registration for the A-CaP in each country, 2nd A-Cap (Asia Pacific Prostate Cancer Registry) Meeting, 08/09/2016 to 08/09/2016, A-Cap Prostate Cancer Registry (International)
  • Expert video session: Multi-energy in prostate surgery, 27th World Congress on Videourology & Advances in Clinical Urology, 09/06/2016 to 11/06/2016, Endourological Society (International)
  • Conventional androgen deprivation therapy and its safety, Asian Prostate Cancer Forum (APCF) 2016, 02/04/2016 to 02/04/2016, Ferring (International)
  • UKMMC ASEAN Laparoscopic Reconstructive Urology Workshop, UKMMC ASEAN Laparoscopic Reconstructive Urology Workshop, 24/08/2015 to 25/08/2015, UKMMC (International)
  • Cairns Consensus Statement: Management of Advanced Prostate Cancer in Asia Pacific, Cairns Consensus Statement: Management of Advanced Prostate Cancer in Asia Pacific, 16/08/2015 to 16/08/2015, A/Prof Dr Declan Murphy, PeterMc Hospital, Melbourne, Australia (International)
  • Chemotherapy in mCRPC, Lecture on Chemotherapy in mCRPC , 18/12/2014 to 18/12/2014, Sanofi-Aventis Malaysia (National)
  • ISI Workshop for Academic Staff, ISI Workshop for Academic Staff, 11/12/2014 to 11/12/2014, UM Library (University)
  • Erectile Dysfunction- Opportunities in the difficult treatment groups, 23rd Malaysian Urological Conference, 22/11/2014 to 22/11/2014, Malaysia Urological Association (National)
  • Plenary 5 Prostate Cancer Discussion, 23rd Malaysian Urological Conference, 21/11/2014 to 21/11/2014, Malaysia Urological Conference (National)
  • Prostate MR Imaging & Biopsy Masterclass, Prostate MR Imaging & Biopsy Masterclass, 31/08/2014 to 31/08/2014, 15th Asia-Pacific Prostate Cancer Conference 2014 (International)
  • ERBE workshop, Urology Workshop, 09/06/2014 to 10/06/2014, Storz (National)
  • Asia Pacific Prostate Cancer Preceptorship Program, Asia Pacific Prostate Cancer Preceptorship Program, 13/05/2014 to 15/05/2014, Charite Hospital, Berlin, Germany (International)
  • Ca Prostate - Diagnosis and staging, Risk stratification and nomograms., Advanced Urology Course: Prostate Cancer, 31/08/2013 to 01/09/2013, Malaysian Urological Association (National)
  • Choosing between different LHRH for locally advanced and metastatic prostate cancer & How 3i pathways help clinicians in patient management, Prostate cancer symposium, 06/06/2013 to 06/06/2013, Menarini (National)
  • Meet-the-expert: Iatrogenic Ureteric Injuries- Immediate Management, Annual General Meeting & Annual Scientific Meeting, The College of Surgeons, Academy of Medicine of Malaysia, 31/05/2013 to 02/06/2013, The College of Surgeons, Academy of Medicine of Malaysia (National)
  • Overcoming Prostate Cancer: New Approaches to an Old Problem, Urofair, Singapore, 08/03/2013 to 08/03/2013, Singapore Urological Association (International)
  • Video Presentations, Urofair, Singapore, 08/03/2013 to 08/03/2013, Singapore Urological Association (International)